Chitosan-based particles as biocompatible delivery vehicles for peptide and protein-based vaccines

Procedia in Vaccinology

Volumn 6, Issue , 2012, Pages 74-79

  Chu, Brendon Y ^a   Kobiasi, Mohammad Al ^b   Zeng, Weiguang ^a   Mainwaring, David ^b   Jackson, David C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Antibody; Chitosan; Dendritic cells; LHRH; Microparticles; Nanoparticles

Indexed keywords

CHITOSAN; FREUND ADJUVANT; GONADORELIN; PEPTIDE VACCINE;

ARTICLE; BIOCOMPATIBILITY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; PRIORITY JOURNAL;

EID: 84860466522     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2012.04.010     Document Type: Article

References (19)

1. Arca H.C., Gunbeyaz M., Senel S. Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 2009, 8(7):937-953.
2. Slutter, B., S.M. Bal, I. Que, E. Kaijzel, C. Lowik, J. Bouwstra, et al., Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles? Mol Pharm. 7(6): 2207-15.
3. Zaharoff D.A., Rogers C.J., Hance K.W., Schlom J.W. Greiner Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 2007, 25(11):2085-2094.
4. Zhou X., Zhang X., Yu X., Zha X., Fu Q., Liu B., et al. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. Biomaterials 2008, 29(1):111-117.
5. Amidi M., Romeijn S.G., Verhoef J.C., Junginger H.E., Bungener L., Huckriede A., et al. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Vaccine 2007, 25(1):144-153.
6. Sui, Z., Q. Chen, F. Fang, M. Zheng, Z. Chen, Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine. 28(48): 7690-8.
7. Amidi, M., H.C. Pellikaan, H. Hirschberg, A.H. de Boer, D.J. Crommelin, W.E. Hennink, et al., Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. Vaccine, 2007. 25(37-38): 6818-29.
8. Sayin B., Somavarapu S., Li X.W., Thanou M., Sesardic D., Alpar H.O., et al. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Int J Pharm 2008, 363(1-2):139-148.
9. Florindo H.F., Pandit S., Goncalves L.M., Videira M., Alpar O., Almeida A.J. Antibody and cytokine-associated immune responses to S. equi antigens entrapped in PLA nanospheres. Biomaterials 2009, 30(28):5161-5169.
10. Xie Y., Zhou N.J., Gong Y.F., Zhou X.J., Chen J., Hu S.J., et al. Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection. World J Gastroenterol 2007, 13(10):1547-1553.
11. Delves P.J., Lund T., Roitt I.M. Antifertility vaccines. Trends Immunol 2002, 23(4):213-219.
12. Chua B.Y., Zeng W., Lau Y.F., Jackson D.C. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups. Vaccine 2007, 25(1):92-101.
13. Talwar G.P., Vyas H.K., Purswani S., Gupta J.C. Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines. J Reprod Immunol 2009, 83(1-2):158-163.
14. Oonk, H.B., J.A. Turkstra, W.M. Schaaper, J.H. Erkens, M.H. Schuitemaker-de Weerd, A. van Nes, et al., New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH. Vaccine, 1998. 16(11-12): 1074-82.
15. Gonzalez G., Lage A. Cancer vaccines for hormone/growth factor immune deprivation: a feasible approach for cancer treatment. Curr Cancer Drug Targets 2007, 7(3):229-241.
16. Kato K., Utani A., Suzuki N., Mochizuki M., Yamada M., Nishi N., et al. Identification of neurite outgrowth promoting sites on the laminin alpha 3 chain G domain. Biochemistry 2002, 41(35):10747-10753.
17. Ghosh S., Jackson D.C. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Int Immunol 1999, 11(7):1103-1110.
18. Zeng W., Gauci S., Ghosh S., Walker J., Jackson D.C. Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH. Vaccine 2005, 23(35):4427-4435.
19. Zeng W., Ghosh S., Lau Y.F., Brown L.E., Jackson D.C. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J Immunol 2002, 169(9):4905-4912.